McLellan TraceyDr TRACEY McLELLAN (Labour): I was just commenting that all this talk about colds made me feel like my nose was running so excuse me if I feel like some pseudoephedrine. We've heard a robust debate tonight about various aspects of a bill that most people are supporting and I think that if we sum that up somehow the three themes are that the bill will be supported; however the process to date has been truncated and it's a real missed opportunity to have not had a more robust process so that some of the potential risks that have been identified could have been mitigated or that the committee and this House could have had the benefit of hearing from people hearing from experts having some more information from agencies and departments into how they may have put together some sort of support around those potential risks. And the third theme I think which has come through quite clearly even more recently is that within a culture of cuts how can we be sure that when these agencies and these departments are facing pressure they don't drop the ball with some of those assumptions that are being made tonight?As we've said Labour will be supporting this bill. It's in line with our history as has been demonstrated in the previous Parliament of being a fan of flexible regulation in relation to medicines. Also it's congruent with our previous moves towards encouraging pharmacies to do more in their space and to take on more treatments as demonstrated by both the Therapeutic Products Act and the minor ailments scheme of the last Government.But as previous colleagues have said I think those three main risks—and I won't go over them in great detail but how will we ensure that pseudoephedrine is safely stored? We've heard the fact that it's going to be in such quantities that it's not even viable or practical to put it under lock and key as we do with many other controlled drugs. I think the issue around tracking it and the issue around having that online real-time register as they do in Queensland is a real missed opportunity for this Parliament not to have sought more information about that. You know that's an innovation that could have been used in various different ways and I think that's a real shame that we didn't take that on.Also we've heard particularly from the Māori Party and the Green Party about the need to never lose sight of the fact that we are here to look at the drivers of addiction and what are the plans for treating those underlying addictions?There's also been a lot of talk about common sense that there's a common-sense approach and whilst that might sound good common sense has never been a huge leader in terms of things always turning out well hence the fact that it is our job to not assume that people are rational actors to not assume that when we're talking about addiction and when we're talking about comorbidities with people with ADHD being the largest consumers of meth for instance there's this linear assumption that a rational decision-making process will take place. So I think that that is a shame. However we will support this bill because at the end of the day you know it is important that people are able to get the medications that they need.My final reservation is the fact that we've talked about pseudoephedrine as being a decongestant which it is. It's also got that stimulatory side effect which just peps us up and helps us feel better without necessarily addressing the underlying cold. Hopefully people don't go back to the good old days where they just went to work and spread their germs around everywhere. Thank you Madam Speaker.